首页> 外文期刊>Science >Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease
【24h】

Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease

机译:丙型肝炎病毒丝氨酸蛋白酶对干扰素调节因子3的调节

获取原文
获取原文并翻译 | 示例
       

摘要

Persistent infections with hepatitis C virus (HCV) are likely to depend on viral inhibition of host defenses. We show that the HCV NS3/4A serine protease blocks the phosphorylation and effector action of interferon regulatory factor -3 (IRF-3), a key cellular antiviral signaling molecule. Disruption of NS3/4A protease function by mutation or a ketoamide peptidomimetic inhibitor relieved this blockade and restored IRF-3 phosphorylation after cellular challenge with an unrelated virus. Furthermore, dominant-negative or constitutively active IRF-3 mutants, respectively, enhanced or suppressed HCV RNA replication in hepatoma cells. Thus, the NS3/4A protease represents a dual therapeutic target, the inhibition of which may both block viral replication and restore IRF-3 control of HCV infection. [References: 28]
机译:持续感染丙型肝炎病毒(HCV)可能取决于病毒对宿主防御系统的抑制作用。我们表明,HCV NS3 / 4A丝氨酸蛋白酶阻断了关键细胞抗病毒信号分子干扰素调节因子-3(IRF-3)的磷酸化和效应子作用。通过突变或酮酰胺拟肽抑制剂破坏NS3 / 4A蛋白酶功能可缓解这种阻断作用,并在用无关病毒攻击细胞后恢复IRF-3磷酸化。此外,显性负性或组成性活性IRF-3突变体分别增强或抑制了肝癌细胞中HCV RNA的复制。因此,NS3 / 4A蛋白酶代表双重治疗靶标,对其的抑制可能既阻断病毒复制又恢复对HCV感染的IRF-3控制。 [参考:28]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号